Sign In
Buy SMMNY
$19.41
-0.370 (-1.87%)
At Close: Jun 03, 2026
AiM Medical Robotics Announces Collaboration Agreement with Siemens Healthineers to Advance MRI-Guided Robotic Neurosurgery
08:25am, Tuesday, 26'th May 2026
Worcester, MA, May 26, 2026 (GLOBE NEWSWIRE) -- AiM Medical Robotics, a leading developer of advanced robotic systems for MRI-guided neurosurgery, today announced a collaboration agreement with Siemen
Siemens Healthineers: Update Post The Carve-Out Announcement
03:26am, Sunday, 10'th May 2026
Siemens Healthineers is rated a 'BUY' with a lowered price target of €48/share and a fair value of €58/share, reflecting recent strategic changes. Recurring revenue, market leadership in imaging a
Siemens Healthineers cuts 2026 outlook
01:07am, Thursday, 07'th May 2026
Siemens Healthineers on Thursday cut its full year outlook to forecast revenue growth of between 4.5% and 5.0% for the 2026 financial year due to weakness in China's diagnostics m
Siemens Healthineers: Razor-And-Blades Model On A China-Driven Dip
12:04pm, Tuesday, 05'th May 2026
Razor and blades model of equipment and then servicing in the healthcare space piques interest here. Free cash flow yields aren't bad for a company with medical end markets and some leading franchises
Tarrytown, NY, USA, May 04, 2026 (GLOBE NEWSWIRE) -- Siemens Healthineers announced its Atellica IM Testosterone II (TSTII) assay has achieved certification through the Centers for Disease Control and
Siemens Healthineers AG (OTCMKTS:SMMNY) Receives Average Rating of “Buy” from Brokerages
04:09am, Monday, 20'th Apr 2026
Shares of Siemens Healthineers AG (OTCMKTS:SMMNY - Get Free Report) have been assigned an average rating of "Buy" from the seven brokerages that are currently covering the firm, Marketbeat reports. Tw
Siemens plans shareholder vote on Siemens Healthineers spin-off in February 2027
07:31am, Friday, 17'th Apr 2026
Siemens said on Friday it planned a shareholder vote on a direct spin-off of Siemens Healthineers shares at its next shareholder meeting in February 2027.
Siemens Healthineers AG (SMMNY) Discusses Q2 Pre-Close Outlook With Focus on Foreign Exchange and Tariff Headwinds Prepared Remarks Transcript
Siemens Healthineers AG (OTCMKTS:SMMNY) Receives Average Rating of “Buy” from Analysts
04:19am, Thursday, 26'th Mar 2026
Siemens Healthineers AG (OTCMKTS:SMMNY - Get Free Report) has been given a consensus rating of "Buy" by the seven brokerages that are covering the stock, Marketbeat Ratings reports. Two investment ana
Imaginostics Receives Siemens Healthineers Letter of Support as Companies Advance Quantitative MRI Dialogue
04:17pm, Friday, 20'th Mar 2026
ORLANDO, Fla.--(BUSINESS WIRE)-- #Alzheimers--Imaginostics, Inc. today announced that it has received a Letter of Support from Siemens Healthineers in connection with ongoing exploratory discussions r
Siemens Healthineers Launches Brain Health Research Portfolio with First Biomarker Assays Now Available
08:30am, Wednesday, 18'th Mar 2026
Brain-derived, fully automated Atellica IM Phosphorylated tau 217 (pTau217) and Atellica IM Brain Derived Tau (BDTau) assays now available for research use Brain-derived, fully automated Atellica IM P
Ki Reply and Data Reply Lay the Strategic Foundation for AI Innovation at Siemens Healthineers with “Cerebra”
05:53am, Monday, 09'th Mar 2026
TURIN, Italy--(BUSINESS WIRE)--Ki Reply and Data Reply, the Reply Group companies specialised respectively in AI-powered software development and data-driven solutions, have partnered with the “CRM
Siemens Healthineers AG (OTCMKTS:SMMNY) Given Average Rating of “Buy” by Analysts
04:48am, Sunday, 01'st Mar 2026
Shares of Siemens Healthineers AG (OTCMKTS:SMMNY - Get Free Report) have been assigned an average recommendation of "Buy" from the seven ratings firms that are covering the stock, Marketbeat reports.
Siemens Healthineers AG (SMMNY) Q1 2026 Earnings Call Transcript
06:54am, Thursday, 05'th Feb 2026
Siemens Healthineers AG (SMMNY) Q1 2026 Earnings Call Transcript
Siemens Healthineers Core Businesses Offset Currency, Tariff Challenges
02:31am, Thursday, 05'th Feb 2026
Revenue grew on a comparable basis as results in its imaging and precision therapy business units offset currency and tariff headwinds.
